ASX:NEU

Email Alerts for:
ASX:NEU

ASX up 0.66% at noon as ASIC proposes advisory group for CHESS

14 Jul 2023 - ASIC plans to establish a stakeholder advisory group to oversee ASX's troubled CHESS replacement project, which ASX supports and sees as a means to enhance transparen…

Stocks of the Hour: Neuren Pharmaceuticals, Green Technology Metals, One Click Group

14 Jul 2023 - A snapshot of the stocks on the move, featuring Neuren Pharmaceuticals (ASX:NEU), Green Technology Metals (ASX:GT1) and One Click Group (ASX:1CG).

Tech and Financials drag ASX: Aus shares close 0.5% lower

13 Mar 2023 - On Monday, the S&P/ASX 200 decreased by 0.5 per cent, or 35.9 points, to 7108.8 due to losses in the financials and technology sectors.

ASX down 0.61% at noon as the SVB saga continues

13 Mar 2023 - The collapse of Silicon Valley Bank has caused concern in the US banking and technology industries, reminding investors of the risks they had ignored. Bank stocks hav…

Stocks of the Hour: Neuren Pharmaceuticals, Metro Mining, Meteoric Resources

13 Mar 2023 - A snapshot of the stocks on the move featuring Neuren Pharmaceuticals (ASX:NEU), Metro Mining (ASX:MMI) and Meteoric Resources (ASX:MEI).

Neuren Pharmaceuticals (ASX:NEU) announces changes leadership team

27 May 2020 - Neuren Pharmaceuticals (ASX:NEU) today announced the appointment of Jon Pilcher and Patrick Davies as Chief Executive Officer and non-executive Chair respectively.

Bank and travel stocks lead losses: Aus shares close 1.7% lower

04 Mar 2020 - The Australian share market opened with more losses this morning and continued to fall in the back half of the trading session closing 1.7 per cent lower. Economy gre…

Neuren Pharmaceuticals (ASX:NEU) see FDA approval for treatment of Rett syndrome

04 Mar 2020 - Acadia Pharmaceuticals Inc. and Neuren Pharmaceuticals (ASX:NEU) announced today that the US Food and Drug Administration (FDA) granted Rare Pediatric Disease (RPD) d…

‘Phase 1’ deal between US and China brings optimism: ASX to open higher

14 Oct 2019 - Following positive leads from US markets, the ASX looks set to open higher this morning. A partial trade deal was secured between China and the US bringing optimism t…

Redbubble upgraded to a buy: Aus shares spike

20 Sep 2019 - The ASX is trading 0.6% higher at midday. All of the sectors are trading in positive territory with Technology and Real Estate leading the way. Goldman Sachs has upgr…

Splitit set to raise $30 million: Aus shares up 1.1% over week

17 May 2019 - The Australian share market finished 0.6 per cent higher today after hitting a new 11 year high early in the session. Despite this, the Australian dollar continued to…

Neuren Pharmaceuticals (ASX:NEU) Presentation, FNN Investor Event, March 2019, Sydney

29 Mar 2019 - Neuren Pharmaceuticals Limited (ASX:NEU) Executive Chairman, Dr Richard Treagus presents on strategy and outlook, provides an update on the company's partnership with…

Neuren Pharmaceuticals (ASX:NEU) targeting neurodevelopmental disorders

02 Apr 2019 - Neuren Pharmaceuticals Limited (ASX:NEU) Executive Chairman, Dr Richard Treagus provides an update on the company's strategy, outlook and partnership with ACADIA Phar…

Energy beams ASX up: Aus shares close 0.51% higher

20 Jul 2017 - Energy beams ASX up: Aus shares close 0.51% higher. Neuren Pharmaceuticals Limited (ASX:NEU) has been grated US Food and Drug Administration (FDA) approval for a face…

Neuren secures funds to progress Rett syndrome trial

29 Jun 2017 - Neuren Pharmaceuticals (ASX:NEU) has secured funding to commence key activities for Phase 3 of its trial, aimed at developing treatment for Rett syndrome.

Edging ahead: Aus shares close 0.12% higher

31 May 2017 - Edging ahead: Aus shares close 0.12% higher. Neuren Pharmaceuticals Limited (ASX:NEU) has received two new patent approvals in the US and Europe for the use of trofin…

Neuren: In trading halt pending clinical trial announcement

20 Mar 2017 - Neuren Pharmaceuticals Limited (ASX:NEU) has entered into a trading halt pending an announcement about its lead product’s clinical trial.

Outlook: Aus shares set to open lower

23 Jun 2016 - Aus shares set to open lower. IMF Bentham Ltd (ASX:IMF) commences law suit against Volkwagen in the courts of Germany.

Neuren to fast track brain drug

31 Dec 2014 - Neuren Pharmaceuticals Limited (ASX:NEU) has taken another important step in the US with its breakthrough drug for brain injuries.

Neuren spikes 54% on Phase 2 trial results

13 Nov 2014 - Shares in Neuren Pharmaceuticals Limited (ASX:NEU) spike after releasing top-line results from its US Phase 2 clinical trial in Rett syndrome.

Midday: Ex dividends, iron price drags ASX

08 Sep 2014 - Following mixed leads, the local bourse opened flat and is trading 0.22 percent lower, with major companies IAG and CSL going ex dividend. WorleyParsons Limited (ASX:…